SRC and cancer: On the other hand, nanomolar concentrations of digoxin have been shown to modulate the nuclear receptor (RORγ)-dependent transcription and several cellular signaling pathways, including HIF-1, Src, NF-κB, and EGFR-STAT3, thereby contributing to its anti-cancer activities [42, 43].